Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons R.Y.J. Tamminga

Publicaties

Occurrence of FVIII Inhibitors in Hemophilia A Patients Following an Institutional Switch to a Third Generation B-Domain-Deleted FVIII

Desmopressin testing in von Willebrand disease: Lowering the burden

A boy with joint pain associated with emicizumab treatment: The importance of plasma level measurement

Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects

Congenital platelet disorders and health status-related quality of life

Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency

One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P (R)/Humate P (R) treatment in von Willebrand disease patients

The Dutch Haemophilia Registry HemoNED - Building an ecosystem

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

Sickle cell disease: Clinical presentation and management of a global health challenge

Lees meer